| Product Name | MF | CAS | Details |
|---|
| Dimethyl Octafluoroadipate | C8H6F8O4 | 3107-98-0 | Details |
| Secoisolariciresinol diferulate | C40H42O12 | 56973-66-1 | Details |
| 5,7,3'-Trihydroxy-6,4',5'-trimethoxyflavone | C18H16O8 | 78417-26-2 | Details |
| N-Desmethyl loperamide | C28H31ClN2O2 | 66164-07-6 | Details |
| 1-Benzyl-2-bromo-4,5,6,7-tetrahydro-1H-benzo[d]imidazole | C14H15BrN2 | 934223-56-0 | Details |
| {4-Ethynylbicyclo[2.2.2]octan-1-yl}methanol | C11H16O | 94994-33-9 | Details |
| 2-(Pyrimidin-2-yl)-1,3-thiazole-5-carbaldehyde | C8H5N3OS | 1235474-02-8 | Details |
| 1,5-Dimethyl citrate | C8H12O7 | 53798-96-2 | Details |
| 7-O-Demethyl rapamycin | C50H77NO13 | 151519-50-5 | Details |
| 5-Chloropyridine-2-sulfonamide | C5H5ClN2O2S | 19506-41-3 | Details |
| ((2-aminophenyl)sulfonyl)(2-phenylethyl)amine | C14H16N2O2S | 23822-95-9 | Details |
| Methyl 3,5-diamino-1H-pyrazole-4-carboxylate | C5H8N4O2 | 1572-13-0 | Details |
| BCTC | C20H25ClN4O | 393514-24-4 | Details |
| Isonicotinic acid | C6H5NO2 | 55-22-1 | Details |
| TMB for Precipitation | Details |
| GSK 256066 trifluoroacetate | C29H27F3N4O7S | 1415560-64-3 | Details |
| 2,5-Diazabicyclo[2.2.2]octane dihydrochloride | C6H14Cl2N2 | 1192-92-3 | Details |
| 2'-O-tert-Butyldimethylsilyl-5'-O-DMT-inosine 3'-CE phosphoramidite | C46H61N6O8PSi | 261518-12-1 | Details |
| Ac-Cys-Nle-Arg-His-D-2-Nal-Arg-Trp-Gly-Cys-NH2 | C58H79N19O10S2 | 212370-59-7 | Details |
| (5-Chloro-pyrimidin-2-yl)-methyl-amine | C5H6ClN3 | 45715-16-0 | Details |
| 2-Chloro-N-(4-chloro-2-nitrophenyl)acetamide | C8H6Cl2N2O3 | 40930-49-2 | Details |
| (4-Ethenyloxan-4-yl)methanol | 2375260-90-3 | Details |
| 6-(1-Ethyl-1H-pyrazol-3-yl)-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid | C14H15N5O2 | 1171838-47-3 | Details |
| 7-Fluoro-5-nitro-2,3-dihydro-1H-indole-2,3-dione | C8H3FN2O4 | 1176058-71-1 | Details |
| STAMBP antibody | Details |
| 4-(4-Heptylphenyl)benzoic Acid | C20H24O2 | 58573-94-7 | Details |
| 4-Phenoxy-2-(trifluoromethyl)aniline | C13H10F3NO | 106877-21-8 | Details |
| α-Ketoglutaric acid potassium | C5H5KO5 | 997-43-3 | Details |
| (3,4-Dimethoxyphenyl)thiourea | C9H12N2O2S | 65069-52-5 | Details |
| 2-Bromobenzene-1-sulfonamide | C6H6BrNO2S | 92748-09-9 | Details |
| 1-[(tert-Butoxy)carbonyl]cyclohexane-1-carboxylic acid | C12H20O4 | 1909348-62-4 | Details |
| Monkey Cystatin C ELISA Kit | Details |
| H-RPHERNGFTVL-OH | Details |
| 2-(Morpholin-2-yl)acetamide | C6H12N2O2 | 135072-28-5 | Details |
| Feline Immunodeficiency Virus (FIV) p24 Antigen, Recombinant | Details |
| 3’-Azido-3’-deoxy-b-L-adenosine | C10H12N8O3 | 216976-76-0 | Details |
| 3-(Quinolin-4-yl)propan-1-amine | C12H14N2 | 379264-82-1 | Details |
| Pinonic acid | C10H16O3 | 473-72-3 | Details |
| HHV6 gp60 + gp100 antibody | Details |
| Urechistachykinin I | C50H85N19O14 | 149097-03-0 | Details |
| 1-Bromo-4-(butan-2-yloxy)benzene | C10H13BrO | 103323-60-0 | Details |
| Methyl 2,3-di-O-acetyl-4,6-O-(4-methoxybenzylidene)-a-D-galactopyranoside | C19H24O9 | Details |
| IGKV15 antibody | Details |
| Methyl (2S)-4-amino-2-hydroxybutanoate hydrochloride | 307316-20-7 | Details |
| Axitinib | C22H18N4OS | 319460-85-0 | Details |
| 2,6-Bis(diphenylamino)anthraquinone | C38H26N2O2 | 868850-50-4 | Details |
| H-Gln-bNA·HCl | C15H18ClN3O2 | 201988-95-6 | Details |
| NEK7 Blocking Peptide | Details |
| 3-(5-Methylthiophen-2-yl)-2,5-dihydro-1,2,4-thiadiazol-5-imine | C7H7N3S2 | 942890-87-1 | Details |
| Cannabigerorcinic acid | C18H24O4 | 69734-83-4 | Details |
| 2,?6-?Dimethyl-thiomorpholine 1,?1-?dioxide hydrochloride | C6H14ClNO2S | 1803601-97-9 | Details |
| Rhodblock 6 | C12H13N3O | 886625-06-5 | Details |
| [4-(2-Chloro-4-nitrophenoxy)-3-fluorophenyl]methanamine hydrochloride | C13H11Cl2FN2O3 | 1315368-51-4 | Details |
| 4-[Ethyl(propan-2-yl)amino]benzoic acid hydrochloride | C12H18ClNO2 | 1235440-24-0 | Details |
| 7-Chloro-3-[(oxolan-2-yl)methyl]-2-sulfanyl-3,4-dihydroquinazolin-4-one | C13H13ClN2O2S | 851169-53-4 | Details |
| Volociximab | 558480-40-3 | Details |
| 3-Benzyl-1H-pyrrole | C11H11N | 33234-57-0 | Details |
| 3-(4-Methanesulfonylphenoxy)propanoic acid | C10H12O5S | 868277-53-6 | Details |
| CA 19-9, Grade II (Low Cross-reactivity), Part Purified | Details |
| PSB-1584 | C10H17N3O2 | 72255-76-6 | Details |
| 2-(5-Bromo-2,3-dioxo-2,3-dihydro-1H-indol-1-yl)-N,N-dimethylacetamide | C12H11BrN2O3 | 1021023-54-0 | Details |
| 4-Methyl-2-(2-oxopiperidin-1-yl)pentanoic acid | C11H19NO3 | 1218277-57-6 | Details |
| (4-Ethyloxan-4-yl)methanamine hydrochloride | C8H18ClNO | 1385696-38-7 | Details |
| 1-Phenoxyhept-6-en-2-one | C13H16O2 | 1339698-04-2 | Details |
| Sulphabenzamide antibody | Details |
| rac-(4aR,8aR)-Octahydro-2H-pyrano[3,2-c]pyridine | C8H15NO | 2007915-59-3 | Details |
| [1-(Difluoromethyl)cyclopropyl]methanamine hydrochloride | C5H10ClF2N | 1785097-21-3 | Details |
| [1-(Oxolan-3-yl)-1H-1,2,3-triazol-4-yl]methanamine dihydrochloride | C7H13ClN4O | 2098001-83-1 | Details |
| 1-Cyclopropyl-3-(methylsulfanyl)propan-1-one | C7H12OS | 1339096-16-0 | Details |
| 4-(4-Methylphenyl)oxane-4-carbonitrile | C13H15NO | 53986-10-0 | Details |
| 1-(2-Methoxyethyl)-4-methyl-1H-pyrazol-3-amine | C7H13N3O | 1344250-05-0 | Details |
| 2-(2-Iodoethoxy)propane | C5H11IO | 318958-37-1 | Details |
| 4-Bromo-7-chloroisoquinoline hydrochloride | C9H6BrCl2N | 1803572-19-1 | Details |
| 3-Bromotricyclo[2.2.1.0,2,6]heptane | C7H9Br | 695-02-3 | Details |
| 2-(4-Bromophenyl)malondialdehyde | C9H7BrO2 | 709648-68-0 | Details |
| Tricyclo[2.2.1.0,2,6]heptane-1-carboxylic acid | C8H10O2 | 697-25-6 | Details |
| 5,6-Dihydro-2H-pyran-3-ylmethanamine hydrochloride | C6H12ClNO | 1803562-50-6 | Details |
| Ethyl 7-fluoroimidazo[1,2-a]pyridine-2-carboxylate | C10H9FN2O2 | 1260798-14-8 | Details |
| H-VLFGLGFAI-OH | Details |
| Ethyl 2-{1,4-dioxaspiro[4.5]decan-6-yl}acetate | C12H20O4 | 57133-55-8 | Details |
| 6-Oxo-N-(prop-2-yn-1-yl)-1,6-dihydropyridine-3-carboxamide | C9H8N2O2 | 1040070-36-7 | Details |
| 1-Methyl-1H,4H,6H,7H-pyrano[4,3-b]pyrrole-2-carboxylic acid | C9H11NO3 | 1536624-40-4 | Details |
| 2-(6-Oxo-4-phenyl-1,6-dihydropyrimidin-1-yl)acetic acid | C12H10N2O3 | 1105193-70-1 | Details |
| 4-?(1,?1-?Dioxido-?2-?isothiazolidinyl)?-piperidine | C8H16N2O2S | 688020-17-9 | Details |
| 1-(4-Chloro-2,6-dimethylphenyl)ethanone | C10H11ClO | 35887-71-9 | Details |
| 2-Amino-N-methyl-N-(thiophen-2-ylmethyl)butanamide hydrochloride | C10H17ClN2OS | 1423025-35-7 | Details |
| 4-(5-Methyl-1H-1,2,3-triazol-1-yl)aniline | C9H10N4 | 84292-45-5 | Details |
| 4-(2-Chlorophenyl)-3,7,7-trimethyl-4H,5H,6H,7H,8H,9H-[1,2]oxazolo[5,4-b]quinolin-5-one | C19H19ClN2O2 | 852712-88-0 | Details |
| 2-(5-Methylfuran-2-yl)propanoic acid | C8H10O3 | 1000004-70-5 | Details |
| Wilforol E | C21H30O3 | 117456-86-7 | Details |
| (1-Benzyl-4-methylpiperazin-2-yl)methanamine | C13H21N3 | 56904-13-3 | Details |
| 2-Butoxypropanoic acid | C7H14O3 | 14620-87-2 | Details |
| 2-{[(4-Methylphenyl)methyl]sulfanyl}-4,5-dihydro-1H-imidazole hydrochloride | C11H15ClN2S | 673434-77-0 | Details |
| CMTM2 Blocking Peptide | Details |
| Lutropin beta antibody | Details |
| 4-Chloro-5-methyl-6-phenylthieno[2,3-d]pyrimidine | C13H9ClN2S | 306934-78-1 | Details |
| Glutathione peroxidase 3 Heavy | Details |
| 5-[(4-Nitrophenyl)methyl]imidazolidine-2,4-dione | C10H9N3O4 | 68319-44-8 | Details |
| 1,2-Di-O-hexadecyl-sn-glycero-3-phospho-N-methylethanolamine | Details |
| Gabrp Blocking Peptide | Details |
| Product Total： Product Page： | ||||
| 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 | ||||